What's Hot

    Ideaya picks most cancers drug candidate, targets human trial software in 2027 (IDYA:NASDAQ) | Invesloan.com

    November 15, 2026

    NTSB says tanker suffered ‘steering casualty’ earlier than New Orleans riverboat crash | Invesloan.com

    November 15, 2026

    I Went Back to India After a H-1B Rejection. It Led to a Great Career. | Invesloan.com

    November 15, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » Ideaya picks most cancers drug candidate, targets human trial software in 2027 (IDYA:NASDAQ) | Invesloan.com
    News

    Ideaya picks most cancers drug candidate, targets human trial software in 2027 (IDYA:NASDAQ) | Invesloan.com

    November 15, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email
    man and his senior father embracing

    Phynart Studio

    Ideaya Biosciences (IDYA) on Sunday said it selected IDE101 as a drug candidate for further development to treat cancers lacking CDKN2A, a gene that normally helps prevent uncontrolled cell growth. The company aims to seek U.S. regulatory permission to begin human testing

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    Budget airways are going upscale with first-class seats and quicker wifi | Invesloan.com

    Peter Schiff warns Ether may fall to $1,000 if $1,600 assist breaks (ETH-USD:Cryptocurrency) | Invesloan.com

    The U.S. is popping extra socialist beneath Trump 2.0, one analyst says. What may change with a Democratic-run Congress? | Invesloan.com

    ULA’s Vulcan returns to flight with 40 Amazon web satellites (BA:NYSE) | Invesloan.com

    Nvidia is gearing up for one among Wall Street’s most anticipated earnings calls in years | Invesloan.com

    China’s hottest shares nowadays have one factor in widespread: names that sound like sheep | Invesloan.com

    Firmus pursues $3B non-public funding after shelving IPO | Invesloan.com

    Will the Anthropic IPO create a disturbance within the broader U.S. fairness market, like SpaceX did? | Invesloan.com

    Gold and silver are supposed to guard towards inflation. So why are each metals tumbling as an alternative? | Invesloan.com

    LATEST NEWS

    Ideaya picks most cancers drug candidate, targets human trial software in 2027 (IDYA:NASDAQ) | Invesloan.com

    November 15, 2026

    NTSB says tanker suffered ‘steering casualty’ earlier than New Orleans riverboat crash | Invesloan.com

    November 15, 2026

    I Went Back to India After a H-1B Rejection. It Led to a Great Career. | Invesloan.com

    November 15, 2026

    Kirk Cousins and the Minnesota Vikings are reunited and it feels so good after win over Green Bay Packers | Invesloan.com

    November 15, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}